BMS 524 (Sprycel 70 mg)
Generic Name: dasatinib
Pill imprint BMS 524 has been identified as Sprycel 70 mg.
Sprycel is used in the treatment of chronic myelogenous leukemia; leukemia; acute lymphoblastic leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Sprycel 70 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- BMS 524
- 70 mg
- Prescription only
- Drug Class:
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Bristol-Myers Squibb
- National Drug Code (NDC):
- Inactive Ingredients:
- croscarmellose sodium
|NDC Code||Manufacturer / Repackager|
|54868-5759||Physicians Total Care Inc (repackager)|
Note: Inactive ingredients may vary.
More about Sprycel (dasatinib)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.